New pill could ease lupus skin rashes in major trial
NCT ID NCT07355218
First seen Jun 25, 2026 · Last updated Jul 17, 2026 · Updated 3 times
Summary
This study tests a drug called enpatoran for people with lupus who have active skin rashes or lesions. About 202 participants will take either enpatoran or a placebo twice daily for 24 weeks, alongside their usual treatments. The goal is to see if the drug can significantly improve skin symptoms.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Enpatoran (a drug taken as a tablet twice daily)
- What this could lead to
- If it works, this could offer a new treatment option for people with lupus-related skin rashes and lesions, potentially reducing their severity.
- What could go wrong
- This is an early Phase 3 trial with only 202 participants, so results may not apply to everyone. The drug may not prove more effective than placebo, and side effects are still being studied.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CUTANEOUS LUPUS ERYTHEMATOSUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Accurate Clinical Research
RECRUITINGHumble, Texas, 77346, United States
-
Accurate Clinical Research Inc. - Lake Charles
RECRUITINGLake Charles, Louisiana, 70605, United States
-
Arthritis and Osteoporosis Consultants of the Carolinas II, LLC
RECRUITINGCharlotte, North Carolina, 28207, United States
-
Bolanos Clinical Research
RECRUITINGPembroke Pines, Florida, 33026, United States
-
Dawes Fretzin Clinical Research Group, LLC
RECRUITINGIndianapolis, Indiana, 46250, United States
-
GTL Medical And Research Group
RECRUITINGMiami, Florida, 33173, United States
-
Inland Rheumatology Clinical Trials, Inc.
RECRUITINGUpland, California, 91786, United States
-
North Texas Center for Clinical Research
RECRUITINGFrisco, Texas, 75034, United States
-
Oakland Hills Dermatology
RECRUITINGAuburn Hills, Michigan, 48326, United States
-
Omega Research Debary, LLC
RECRUITINGDeBary, Florida, 32713, United States
-
South Florida Rheumatology
RECRUITINGHollywood, Florida, 33026, United States
-
The Medical Arts Health Research Group - 300128547
RECRUITINGKelowna, British Columbia, V1Y 4Z5, Canada
-
Vantage Clinical Trials
RECRUITINGTampa, Florida, 33603, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Continued anifrolumab treatment studied for lupus and related diseases
- Scientists probe hidden clot risks in autoimmune skin disorders
- Psoriasis cream could tame lupus skin flares
- New pill aims to tame painful lupus skin flares
- New lupus drug candidate begins first safety tests in humans
- 1,000 lupus patients join hunt for skin disease genes